ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 102 filers reported holding ORIC PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $22,622,061 | -42.9% | 3,199,726 | +11.0% | 0.00% | -100.0% |
| Q1 2024 | $39,628,257 | +91.2% | 2,882,055 | +27.9% | 0.00% | – |
| Q4 2023 | $20,723,175 | +32.3% | 2,252,519 | -13.0% | 0.00% | – |
| Q3 2023 | $15,662,657 | +12.3% | 2,588,869 | +44.1% | 0.00% | – |
| Q2 2023 | $13,944,922 | +48.9% | 1,797,026 | +9.4% | 0.00% | – |
| Q1 2023 | $9,365,522 | +2.8% | 1,643,074 | +6.3% | 0.00% | – |
| Q4 2022 | $9,107,619 | +111.3% | 1,546,285 | +14.8% | 0.00% | – |
| Q3 2022 | $4,310,000 | -31.9% | 1,346,862 | -4.7% | 0.00% | – |
| Q2 2022 | $6,333,000 | -27.9% | 1,413,731 | -14.0% | 0.00% | – |
| Q1 2022 | $8,779,000 | -63.4% | 1,644,019 | +0.9% | 0.00% | -100.0% |
| Q4 2021 | $23,960,000 | -28.3% | 1,630,038 | +1.9% | 0.00% | 0.0% |
| Q3 2021 | $33,433,000 | +53.2% | 1,598,922 | +29.6% | 0.00% | 0.0% |
| Q2 2021 | $21,828,000 | -29.0% | 1,233,870 | -1.7% | 0.00% | 0.0% |
| Q1 2021 | $30,752,000 | +4.7% | 1,255,207 | +44.7% | 0.00% | 0.0% |
| Q4 2020 | $29,366,000 | +175.5% | 867,551 | +103.6% | 0.00% | – |
| Q3 2020 | $10,659,000 | -26.3% | 426,166 | -0.6% | 0.00% | -100.0% |
| Q2 2020 | $14,460,000 | – | 428,714 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $4,673,631 | 14.75% |
| Nextech Invest Ltd. | 4,285,714 | $33,257,141 | 11.30% |
| Column Group LLC | 3,568,181 | $27,689,085 | 10.75% |
| Prosight Management, LP | 5,522,936 | $42,857,984 | 6.42% |
| Invus Financial Advisors, LLC | 1,007,575 | $7,818,782 | 4.18% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,450,822 | $11,258,379 | 3.48% |
| VR Adviser, LLC | 2,142,856 | $16,628,563 | 2.66% |
| Euclidean Capital LLC | 747,550 | $5,800,988 | 1.49% |
| Frazier Life Sciences Management, L.P. | 2,142,855 | $16,628,555 | 0.99% |
| Monaco Asset Management SAM | 378,222 | $2,935,003 | 0.82% |